| |
| |
| |
| |
| |
|
Anti-cancer drugs with immunoprotective/immunomodulatory effect
Říhová, Blanka ; Etrych, Tomáš ; Kovář, Marek ; Chytil, Petr ; Hovorka, Ondřej ; Plocová, Daniela ; Mrkvan, Tomáš ; Strohalm, Jiří ; Šírová, Milada ; Šubr, Vladimír ; Kubáčková, K. ; Ulbrich, Karel
Cytotoxic drugs based on HPMA polymer show direct cytotoxic and cytostatic effect together with an ability to mobilize the immune system. Two types of linkage of the drug to the polymer are discussed, as well as linkage-related differences in tumour cell accumulation and fate of the cells
|
|
Dual cytostatic and immunostimulate activity of polymericdrugs
Říhová, Blanka ; Strohalm, Jiří ; Kubáčková, K. ; Jelínková, Markéta ; Rozprimová, L. ; Kovář, Marek ; Šírová, Milada ; Plocová, Daniela ; Mrkvan, Tomáš ; Etrych, Tomáš ; Pokorná, Jindřiška ; Ulbrich, Karel
Classic chemotherapy is toxic for all intensively proliferated cells and tissues.
|
|
Activity of doxorubicin bound to polymeric carrier, containing human IgG was followed in four patients with breast carcinoma
Pokorná, Jindřiška ; Strohalm, Jiří ; Kubáčková, K. ; Jelínková, Markéta ; Rozprimová, L. ; Šírová, Milada ; Plocová, Daniela ; Etrych, Tomáš ; Ulbrich, Karel ; Říhová, Blanka
More than 116 biochemical and immunological parameters wasfollowed in patients with carcinoma.
|
|
Immunological activity of HPMA-doxorubicine copolymer: experiment and clinical study
Šírová, Milada ; Strohalm, Jiří ; Kubáčková, K. ; Rozprimová, L. ; Jelínková, Markéta ; Kovář, Marek ; Mrkvan, Tomáš ; Pokorná, J. ; Renčiuk, Daniel ; Etrych, Tomáš ; Ulbrich, Karel ; Říhová, Blanka
Cytostatics bound to various types of polymers representone of the most promising ways in treatment of cancer.
|
|
Antracyklinová antibiotika na bázi protilátkou směrovaného HPMA
Říhová, Blanka ; Strohalm, Jiří ; Jelínková-Ibrahimová, Markéta ; Kovář, Marek ; Šubr, Vladimír ; Etrych, Tomáš ; Mrkvan, Tomáš ; Šťastný, Marek ; Plocová, Daniela ; Šírová, Milada ; Hovorka, Ondřej ; Kubáčková, K. ; Ulbrich, Karel
Conjugates based on N-(2-hydroxypropyl)methacrylamide represent a new generation of polymeric anticancer drugs with improved therapeutic potential and considerably decreased nonspecific side effects. Antibody -targeted derivatives show specific active targeting and nonspecific passive accumulation in solid tumors.
|